Working Groups

Active?
Facet Toggle

Working Group on a New Grand Bargain for Antimicrobial Procurement
Amanda Glassman
et al.
June 27, 2022
While there have been high-level commitments from the World Health Assembly, the United Nations General Assembly (UNGA), the G20, and the G7 to tackle AMR, there has yet to be a fundamental change in how we purchase antimicrobials, or an international approach to improving access, fostering innovati...
Next Generation Financing Models in Global Health
Amanda Glassman
et al.
August 19, 2015
Drug Resistance Working Group (November 2007 – June 2010)
Amanda Glassman
and
Prashant Yadav
September 10, 2014
Value for Money: An Agenda for Global Health Funding Agencies
Amanda Glassman
et al.
August 25, 2014
As international commitments become more ambitious and aid resources become increasingly constrained, global health funding agencies are seeking to improve the efficiency and impact of their investments. This growing “value for money” (VfM)  agenda aims to reduce costs, increase imp...
Beyond the Fence Study Group
Alan Gelb
et al.
July 10, 2014
The Beyond the Fence Study Group generates rigorous new research to explore how policy decisions on one side of the US-Mexico border ripple to the other side through illicit markets and to inform a policy debate on more bilateral approaches to innovative regulation.